Bokus

Anne B. Claiborne

Visar alla böcker från författaren Anne B. Claiborne. Handla med fri frakt och snabb leverans.

  1. Building a National Framework for the Establishment of Regulatory Science for Drug Development

    Building a National Framework for the Establishment of Regulatory Science for Drug Development

    2011

  2. Advancing Regulatory Science for Medical Countermeasure Development

    Advancing Regulatory Science for Medical Countermeasure Development

    2011

  3. Advancing Regulatory Science for Medical Countermeasure Development

    Advancing Regulatory Science for Medical Countermeasure Development

    2011

  4. Public Engagement and Clinical Trials

    Public Engagement and Clinical Trials

    2012

  5. Facing the Reality of Drug-Resistant Tuberculosis in India

    Facing the Reality of Drug-Resistant Tuberculosis in India

    2012

  6. Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

    Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

    2012

  7. Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

    Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

    2012

  8. Envisioning a Transformed Clinical Trials Enterprise in the United States

    Envisioning a Transformed Clinical Trials Enterprise in the United States

    2012

  9. Accelerating the Development of New Drugs and Diagnostics

    Accelerating the Development of New Drugs and Diagnostics

    2012

  10. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

    Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

    2013

  11. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

    Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

    2013

  12. Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

    Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

    2014

  13. Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

    Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

    2014

  14. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

    Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

    2014

  15. Global Health Risk Framework

    Global Health Risk Framework

    2016

  16. Advancing the Discipline of Regulatory Science for Medical Product Development

    Advancing the Discipline of Regulatory Science for Medical Product Development

    2016

  17. Advancing the Discipline of Regulatory Science for Medical Product Development

    Advancing the Discipline of Regulatory Science for Medical Product Development

    2016

  18. Real-World Evidence Generation and Evaluation of Therapeutics

    Real-World Evidence Generation and Evaluation of Therapeutics

    2017